Title:
【発明の名称】5α-レダクターゼ阻害剤としての新規Δ-17-及びΔ-20オレフィン性並びに飽和17β-置換4-アザ-5α-アンドロスタン-オン
Document Type and Number:
Japanese Patent JPH07508032
Kind Code:
A
Abstract:
PCT No. PCT/US93/04630 Sec. 371 Date Nov. 14, 1994 Sec. 102(e) Date Nov. 14, 1994 PCT Filed May 17, 1993 PCT Pub. No. WO93/23051 PCT Pub. Date Nov. 25, 1993.Described are delta 17 and delta 20 olefinic and saturated 17 Beta-substituted 4-aza-5 alpha-androstan-3-ones and related compounds having 5 alpha reductase inhibitors for treatment of benign prostatic hyperplasia and other hyperandrogenic related disorders.
Inventors:
Donald Davour, Graham
Astor, Susan Day
Tallman, Littleyard El
Astor, Susan Day
Tallman, Littleyard El
Application Number:
JP50377894A
Publication Date:
September 07, 1995
Filing Date:
May 17, 1993
Export Citation:
Assignee:
Merck End Company, Inc.
International Classes:
A61K8/63; A61K8/00; A61K31/58; A61Q5/00; A61Q7/00; A61Q19/00; C07J73/00; (IPC1-7): C07J73/00; A61K7/00; A61K7/06; A61K7/48; A61K31/58
Domestic Patent References:
| JP3016948B | ||||
| JP1502641Y |
Foreign References:
| US4775371A | 1988-10-04 | |||
| US4690175A | 1987-09-01 |
Attorney, Agent or Firm:
Yoshio Kawaguchi (2 outside)